Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma

References

• Boberg KM, Lind GE. Primary sclerosing cholangitis and malignancy. Best Pract Res Clin Gastroenterol. 2011;25:753–764.
   PubMed Web of Science ®Google Scholar
• Boonstra K, Weersma RK, van Erpecum KJ, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology. 2013;58:2045–2055.
   PubMed Web of Science ®Google Scholar
• Boberg KM, Bergquist A, Mitchell S, et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol. 2002;37:1205–1211.
   PubMed Web of Science ®Google Scholar
• Chapman MH, Webster GJ, Bannoo S, et al. Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience. Eur J Gastroenterol Hepatol. 2012;24:1051–1058.
   PubMed Web of Science ®Google Scholar
• Razumilava N, Gores GJ, Lindor KD. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology. 2011;54:1842–1852.
   PubMed Web of Science ®Google Scholar
• Lewis JT, Talwalkar JA, Rosen CB, et al. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma. Am J Surg Pathol. 2010;34:27–34.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237–267.
   PubMed Web of Science ®Google Scholar
• Boberg KM, Jebsen P, Clausen OP, et al. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol. 2006;45:568–574.
   PubMed Web of Science ®Google Scholar
• Halme L, Arola J, Numminen K, et al. Biliary dysplasia in patients with primary sclerosing cholangitis: additional value of DNA ploidity. Liver Int. 2012;32:783–789.
   PubMed Web of Science ®Google Scholar
• Trilianos P, Selaru F, Li Z, et al. Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis. Digestion. 2014;89:165–173.
   PubMed Web of Science ®Google Scholar
• Trikudanathan G, Navaneethan U, Njei B, et al. Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Gastrointest Endosc. 2014;79:783–789.
   PubMed Web of Science ®Google Scholar
• Aishima S, Kubo Y, Tanaka Y, et al. Histological features of precancerous and early cancerous lesions of biliary tract carcinoma. J Hepatobiliary Pancreat Sci. 2014;21:448–452.
   PubMed Web of Science ®Google Scholar
• Barr Fritcher EG, Kipp BR, Halling KC, et al. FISHing for pancreatobiliary tract malignancy in endoscopic brushings enhances the sensitivity of routine cytology. Cytopathology. 2014;25:288–301.
   PubMed Web of Science ®Google Scholar
• Lindberg B, Arnelo U, Bergquist A, et al. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Endoscopy. 2002;34:909–916.
   PubMed Web of Science ®Google Scholar
• Boyd S, Tenca A, Jokelainen K, et al. Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia. Endoscopy. 2016.;48:432–439.
   PubMed Web of Science ®Google Scholar
• Sinakos E, Saenger AK, Keach J, et al. Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma. Clin Gastroenterol Hepatol. 2011;9:434–439.
   PubMed Web of Science ®Google Scholar
• Yanai H, Matalon S, Rosenblatt A, et al. Prognosis of primary sclerosing cholangitis in Israel is independent of coexisting inflammatory bowel disease. J Crohns Colitis. 2015;9:177–184.
   PubMed Web of Science ®Google Scholar
• Navaneethan U, Venkatesh PG, Jegadeesan R, et al. Comparison of outcomes for patients with primary sclerosing cholangitis associated with ulcerative colitis and Crohn's disease. Gastroenterol Rep. 2016;4:43–49.
   Google Scholar
• Venkatesh PG, Navaneethan U, Shen B, et al. Increased serum levels of carbohydrate antigen 19-9 and outcomes in primary sclerosing cholangitis patients without cholangiocarcinoma. Dig Dis Sci. 2013;58:850–857.
   PubMed Web of Science ®Google Scholar
• Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660–678.
   PubMed Web of Science ®Google Scholar
• Ishii Y, Sasaki T, Serikawa M, et al. Elevated expression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 in primary sclerosing cholangitis: implications for cholangiocarcinogenesis. Int J Oncol. 2013;43:1073–1079.
   PubMed Web of Science ®Google Scholar
• Rubin DT, Huo D, Kinnucan JA, et al. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. Clin Gastroenterol Hepatol. 2013;11:1601–1608.
   PubMed Web of Science ®Google Scholar
• Nieminen U, Jussila A, Nordling S, et al. Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: a case-control observational study based on registry data. Int J Cancer. 2014;134:189–196.
   PubMed Web of Science ®Google Scholar
• Färkkilä M, Karvonen AL, Nurmi H, et al. Treatment of primary sclerosing cholangitis with a combination of metronidazole and ursodeoxycholic acid: a 3-year randomized placebo-controlled trial. Hepatology. 2004;40:1379–1386.
   PubMed Web of Science ®Google Scholar
• Kerr SE, Barr Fritcher EG, Campion MB, et al. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma. Hum Pathol. 2014;45:1797–1804.
   PubMed Web of Science ®Google Scholar
• Ismail S, Kylänpää L, Mustonen H, et al. Risk factors for complications of ERCP in primary sclerosing cholangitis. Endoscopy. 2012;44:1133–1138.
   PubMed Web of Science ®Google Scholar
• Bangarulingam SY, Gossard AA, Petersen BT, et al. Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis. Am J Gastroenterol. 2009;104:855–860.
   PubMed Web of Science ®Google Scholar
• Thosani N, Banerjee S. Endoscopic retrograde cholangiopancreatography for primary sclerosing cholangitis. Clin Liver Dis. 2014;18:899–911.
   PubMed Web of Science ®Google Scholar
• Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10:639–645.
   PubMed Web of Science ®Google Scholar